Thu.May 11, 2023

article thumbnail

Mental Health Awareness Month: Fighting the growing mental health crisis and supporting innovation

PhRMA

America is currently facing a mental health crisis — one that is impacting families and individuals in every community, with the COVID-19 pandemic only exacerbating these trends. Mental Health Awareness Month, which is held each year in May, presents an opportunity to discuss ways to address the growing burden of, and stigma surrounding, mental illness.

213
213
article thumbnail

Regardless of Age and Season, Patients Should be Screened for a Range of Respiratory Viruses

Drug Topics

Patients should be screened regardless of age, gender, or time of year.

187
187
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

BioNTech’s RNA vaccine sparks potential in pancreatic cancer

Pharmaceutical Technology

Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later. In the study, 16 patients were treated with a vaccine called autogene cevumeran that contained a maximum of 20 neoantigens, alongside Roche’s anti-PD-L1 immunotherapy Tecentriq (atez

Vaccines 138
article thumbnail

Study Associates Low-Dose, Daily Vitamin D3 With Statistically Significant Reduction in Cancer Mortality

Pharmacy Times

A daily low-dose form of vitamin D3 was more effective on cancer mortality than intake of a monthly high-dose form, especially for adults aged 70 years and older.

130
130
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

STAT+: How the FDA’s pandemic flexibilities boosted mental health apps — and what happens now

STAT

In April 2020, the Food and Drug Administration announced a pandemic enforcement policy allowing mental health app developers to release certain treatment products without seeking authorization from the agency. With the end of the official public health emergency, companies that did so will now need to submit the products for FDA clearance and have them pass an early stage of review by early November — or remove the products from the market.

FDA 126
article thumbnail

Microbiota-Based Living Therapeutics Provide Similar Value to Ecological Restoration, Helping Patients With C. diff Restore Their Microbiota

Pharmacy Times

Patients with C. difficile who received clonal bacteria populations via biotherapeutic injection were able to repopulate their microbiota with commensal bacteria.

123
123

More Trending

article thumbnail

Deprescribing Benzodiazepines in Older Adults: An Anesthesiology Quality Initiative

Pharmacy Times

A novel collaboration between the University of Pennsylvania and US Anesthesia Partners is working to drive evidence-based change in benzodiazepine use.

123
123
article thumbnail

STAT+: Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform

STAT

WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at speeding generic drug competition and reining in drug middlemen business practices. But they failed to pass an ambitious reform to the pharmacy benefit manager sector, despite strong bipartisan support for it. Chairman Bernie Sanders (I-Vt.) is pursuing the drug pricing reforms at the behest of Senate Majority Leader Chuck Schumer (D-N.Y.), who wants to hold a floor vote on an even bigger package of he

Packaging 117
article thumbnail

Pharmacists Are in Key Positions to Tackle Black Maternal Mortality Disparities

Pharmacy Times

Tackling racial disparities among health care providers can help improve disparities faced by patients.

145
145
article thumbnail

Industry Voices—Where we go from here: Community pharmacy in a post-pandemic world

Fierce Healthcare

Industry Voices—Where we go from here: Community pharmacy in a post-pandemic world pminemyer Thu, 05/11/2023 - 14:47

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

First Treatment for Agitation Associated With Alzheimer Disease Dementia Approved by FDA

Drug Topics

Data from two phase 3 studies showed that brexpiprazole 2 mg or 3 mg doses significantly improved symptoms of agitation in patients with AAD.

FDA 98
article thumbnail

Payers uniquely positioned to enhance health equity, United Hospital Fund report says

Fierce Healthcare

Payers uniquely positioned to enhance health equity, United Hospital Fund report says agliadkovskaya Thu, 05/11/2023 - 10:07

Hospitals 132
article thumbnail

Follow Stepwise Approach to Manage Allergic Asthma

Pharmacy Times

This treatment approach helps reduce symptoms and future exacerbations triggered by dust mites, pet dander, pollen.

123
123
article thumbnail

WHO ends global health emergency over mpox

STAT

The World Health Organization ended the global health emergency for mpox  on Thursday, saying that while the virus continues to spread internationally, steady progress has been made in controlling the outbreak. The decision, announced by WHO Director-General Tedros Adhanom Ghebreyesus, came less than a week after the U.N. health agency announced the termination of the global health emergency for Covid-19.

102
102
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

IQVIA reports medicine spending rose in 2022 due to COVID vaccines, therapies

Drug Store News

Spending on medicines—at net manufacturer prices—reached $429 billion in 2022, growing 5.3% including the continued contribution of COVID-19 vaccines and therapeutics, the report revealed.

article thumbnail

STAT+: Wyden decries ‘astonishingly low’ tax rates for pharma companies as he probes business maneuvers

STAT

Thanks to changes in tax law six years ago, several of the largest pharmaceutical companies saw their tax rates fall substantially, but they also reported that most of their profits were shifted offshore in an effort to avoid paying U.S. taxes, according to a memo by a U.S. Senate Committee. Specifically, the average effective tax rate for seven of the biggest drug makers fell by 40% — dropping to 11.6% in 2020, down from 19.6% in 2016.

article thumbnail

To Deliver Cell and Gene Therapies to More Patients, Innovation in Diagnostic Testing is Essential

Pharmacy Times

Individualized treatments like cell and gene therapies are poised to scale rapidly over the next decade.

123
123
article thumbnail

Opinion: Fear-based messaging doesn’t stop drug use. But it does make things worse

STAT

It “rots” flesh. It “tears” bone. It will turn you into a “zombie.” According to Senate Majority Leader Chuck Schumer and his colleagues, these are some of the  reasons we should fear  and  criminalize  xylazine, a veterinary sedative and painkiller that is  increasingly  found in drugs purchased on the U.S. illicit market.

98
article thumbnail

Asthmatics at elevated risk of cancer, study finds

Hospital Pharmacy Europe

A US study suggests a higher cancer risk among asthmatics, though inhaled steroid use may offer a protective effect against cancer. Cancer is the leading global cause of mortality, with nearly 10 million recorded deaths in 2020. Moreover, it is suggested that infection and inflammation contribute to a quarter of all cancers. It appears that the inflammatory milieu within a tumour is an indispensable participant in tumour progression.

article thumbnail

STAT+: Scientists use ‘mini-brains’ to study microglia, the brain’s cleanup crew and key players in neurological disease

STAT

Home to billions of cells that form trillions of connections, the human brain isn’t just the body’s most important organ, it’s also the hardest to study. But an international team of scientists using cutting-edge stem cell technology has devised a new way to better understand the brain’s cellular cleanup crew — and its connection to neurological disease.

article thumbnail

The pharmacist’s role in women’s health

The Checkup by Singlecare

Women of all ages face unique health concerns that may affect their overall health and well-being. As highly accessible healthcare professionals, pharmacists are well-positioned to support women’s health in their communities throughout the year. Pharmacists can have a significant impact on women’s health by providing education, counseling, and medication management services.

article thumbnail

A former health insurance executive turns to tech to make claims less of a nightmare

STAT

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.

article thumbnail

Kiss Products, RTRO partner on positivity-focused social media platform

Drug Store News

The partnership aims to help create safe space conversations to engage creators and consumers in an ongoing dialogue promoting mental well-being throughout May.

98
article thumbnail

R.J. Reynolds sues California to protect ‘crisp’ cigarettes from flavor ban

STAT

WASHINGTON – Tobacco giant R.J. Reynolds is suing the state of California in an effort to keep a controversial new line of cigarettes on shelves, the company announced Thursday in a press release. R.J. Reynolds launched the products in question shortly after California voters endorsed a statewide ban on menthol cigarettes. It’s advertising these cigarettes, marketed under Reynolds’ popular menthol brands, Camel Crush and Newport, as being “crisp” and producing

FDA 98
article thumbnail

Majority of Antidepressants Used for Treatment of Chronic Pain Lack Sufficient Efficacy, Safety Data

Drug Topics

A new meta-analysis found duloxetine to be the only commonly prescribed medication that was effective.

98
article thumbnail

STAT+: AbbVie sues a behind-the-scenes company for exploiting its patient assistance program

STAT

AbbVie has filed a lawsuit against a behind-the-scenes company that helps health plan sponsors take advantage of the assistance programs created by drug companies to provide specialty medicines to patients for free. At issue is a maneuver called alternative funding, which a growing number of drug makers contend exploits their charitable programs. Basically, a plan sponsor excludes certain expensive drugs from coverage and taps an outside vendor to help uninsured and underinsured patients obtain

98
article thumbnail

After Shkreli's run in with the law, Pharma Bro's former company Vyera files for bankruptcy

Fierce Pharma

After Shkreli's run in with the law, Pharma Bro's former company Vyera files for bankruptcy fkansteiner Thu, 05/11/2023 - 11:06

108
108
article thumbnail

Kellogg’s Rice Krispies Treats, Ludacris kick off “Treat. Eat. Compete” game set

Drug Store News

Sales from the limited-edition game set will support Boys & Girls Clubs of America to foster moments of connection nationwide, the company said.

98
article thumbnail

Humana partners with 2 durable medical equipment companies for home care

Fierce Healthcare

Humana partners with 2 durable medical equipment companies for home care pminemyer Thu, 05/11/2023 - 14:19

116
116
article thumbnail

STAT+: Pharmalittle: FDA panel recommends first OTC birth control pill; Senate hearing on insulin costs satisfies no one

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, as we gaze at birds on the nearby telephone wire and the official mascot curls up for a much-needed nap. Meanwhile, we are perusing our ever-growing to-do list and firing up the trusty coffee kettle to brew yet another cup of stimulation. As always, you are invited to join us.

FDA 98
article thumbnail

MultiPlan shells out $160M for analytics AI company Benefits Science

Fierce Healthcare

MultiPlan shells out $160M for analytics AI company Benefits Science aburky Thu, 05/11/2023 - 19:26

119
119
article thumbnail

Schnucks kicks off 6th annual “Round Up at the Register” to benefit Folds of Honor

Drug Store News

In addition to military families, nonprofit organization now provides scholarships to family members of fallen and disabled first responders.

97
article thumbnail

Ochsner Health cutting 770 jobs to reverse 2022's nine-figures losses

Fierce Healthcare

Ochsner Health cutting 770 jobs to reverse 2022's nine-figures losses dmuoio Thu, 05/11/2023 - 10:39

115
115
article thumbnail

FDA Approves First-Of-Its-Kind Eye Spray

Drug Topics

The company that developed the treatment said it will benefit "millions" of patients.

FDA 98